During past two decades, plant-derived bioactive compounds have
been reported as novel therapeutic agents for prevention and/or mitigation of different human diseases such as
cancer, inflammation, cardiovascular and neurodegenerative diseases. Hesperidin is known as one of the most
common and bioactive constituents of Citrus (C) species which possesses multiple health-promotion effects.
A plethora of scientific literature reported that hesperidin possesses in-vitro and in-vivo anticancer activities.
In addition, there are numerous scientific evidences regarding the molecular mechanisms of anticancer activities
of hesperidin and its aglycone, hesperetin. However, in this case, the number of comprehensive reviews
on molecular mechanisms underlying the anticancer effects of hesperidin is sparse. Therefore, in this work we
present a critical review of the available literature regarding the molecular mechanisms of the anticancer effects
of hesperidin and its aglycone, hesperetin.